North East and North Cumbria
ICS Formulary
ICS Formulary
9 Nutrition and blood
09-01-01-02 Parenteral iron
| Ferric Carboxymaltose 100ml in 2ml & 500mg in 10ml injections Ferinject® |
|
Formulary
|
|
 MHRA Drug Safety Update (Nov 2020): Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures |
|
Links
- County Durham and Tees Valley Guidance for Prescribing & Monitoring Post Bariatric Surgery
- County Durham and Tees Valley Guidelines for recognition and management of non- IgE cow’s milk allergy in children
- Guidance for the Prescribing of Vitamins and Minerals in Primary Care in County Durham and Tees Valley
- MHRA Drug Safety Update (Dec 2014): Intravenous iron and serious hypersensitivity reactions
- MHRA Drug Safety Update (Nov 2020): Ferric carboxymaltose (Ferinject▼): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures
- NICE NG203: Chronic kidney disease: assessment and management
North of Tyne, Gateshead and North Cumbria - Recommendations for symptom management in renal patients (including symptom management at the end of life)- South Tees Pathway for the Management of Undernutrition (ADULTS)
- South Tees Pathway for the Management of Undernutrition (Nursing/Care Homes)